AWARDDEFINITIVE CONTRACTSmall business
Definitive contract 75F40123C00140INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC.
Overview
Award facts
- Net obligations
- $263.02K
- $263,016of $263.02K potential value
- Outlays (paid to date)
- $263.02K
- $263.02K paid of $263.02K obligated$263,016
- Period of performance
- Sep 18, 2023 to Jun 24, 2025
- Ended
- Modifications
- 3
- Latest action Jun 24, 2025
- Contract type
- Definitive contract
- PIID 75F40123C00140
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
THIS IS A FIRM FIXED PRICE CONTRACT FOR DEVELOPMENT OF MODERNIZED SUSCEPTIBILITY GUIDANCE FOR AMPICILLIN AND VANCOMYCIN FOR ENTEROCOCCUS SPECIES USING PHARMACOMETRIC APPROACHES
Dates and value
- Award date
- Signed on Sep 18, 2023
- Potential end of performance
- Jun 23, 2025
- Current value
- $263,016Base and exercised options
- Potential value (if all options are exercised)
- $263,016
Obligations by fiscal year of action
- FY2023: $263,016
Total across 1 fiscal year: $263,016
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jun 24, 2025. View on USAspending · Recipient on SAM.gov
Recipient
LocationSCHENECTADY, NY
UEIZ82HHPY83MC7
CAGE code6Y2X5
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyINSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC.
Business types and certifications
Minority-ownedFor-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded from
- Human drugsProgram activities075-0600Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Schenectady, New York 12305-2504
- Congressional district (place of performance)
- NY-20As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- B529SPECIAL STUDIES/ANALYSIS- SCIENTIFIC DATA (service)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Two stepTS
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 1
Contract details
- Subcontracting plan
- Plan not requiredB
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Sep 18, 2023Base obligation at award: $263,016
- Latest action
- Jun 24, 2025 — Other administrative actionModification P00003; administrative: no change in scope or value
- Latest substantive action
- Aug 5, 2024 — Supplemental agreement (within scope)Modification P00002
- Actions by type
- Base award1
- Supplemental agreement (within scope)1
- Change order1
- Other administrative action1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Simplified procedures for commercial items
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7524
- Contracting office code
- 75F401
- Transactions recorded under this award key
- 4
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7524
- Funding office code
- 75F401
- Treasury accounts
- 075-2023/2023-0600-000
- Object classes
- 25.5: Research and development contracts
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression